Antibody and B‐Cell Responses to PHH‐1V81 XBB.1.16‐Adapted SARS‐CoV‐2 Booster Vaccination Are Associated With Variant Neutralization

Documenti analoghi

• Correction to “Modeling Antibody Kinetics Post‐mRNA Booster Vaccination and Protection Durations Against SARS‐CoV‐2 Infection”
  Pubblicazione: (2025)
• Discovery of a Novel Public Antibody Lineage Correlated With Inactivated SARS‐CoV‐2 Vaccine and the Resultant Neutralization Activity
  di: Jing Wang, et al.
  Pubblicazione: (2024)
• Malaria and other infections induce polyreactive antibodies that impact SARS‐CoV‐2 seropositivity estimations in endemic settings
  di: Ruth Aguilar, et al.
  Pubblicazione: (2024)
• A Novel Circular Delta‐XBB.1.5 RBD Dimeric Protein Subunit Vaccine Mediated by Split Intein Elicits an Immune Response and Protection Against Multiple SARS‐CoV‐2 Variants in Mice
  di: Kangyin Li, et al.
  Pubblicazione: (2024)
• Erratum to “Evaluation of the Effectiveness and Safety of Sequential Vaccination With Inactivated SARS‐CoV‐2 Vaccine and Ad5‐nCoV Booster in Pediatric Liver Transplant Recipients”
  Pubblicazione: (2024)